
Smith & Nephew plc SNN
$ 32.33
0.53%
Annual report 2024
added 03-14-2026
Smith & Nephew plc Operating Expenses 2011-2026 | SNN
Annual Operating Expenses Smith & Nephew plc
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 2.67 B | 2.81 B | 2.6 B | 2.56 B | 2.5 B | 2.6 B | 2.56 B | 2.37 B | 2.15 B | 2.27 B |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.81 B | 2.15 B | 2.51 B |
Operating Expenses of other stocks in the Medical devices industry
| Issuer | Operating Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Alphatec Holdings
ATEC
|
614 M | $ 11.77 | 0.17 % | $ 1.77 B | ||
|
BioSig Technologies
BSGM
|
12.9 M | - | 37.08 % | $ 85.7 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
79 M | - | - | $ 1.77 B | ||
|
Delcath Systems
DCTH
|
72.8 M | $ 9.2 | 2.45 % | $ 330 M | ||
|
Axonics Modulation Technologies
AXNX
|
263 M | - | - | $ 3.31 B | ||
|
Aziyo Biologics
AZYO
|
33.5 M | - | 1.37 % | $ 20.5 M | ||
|
Acutus Medical
AFIB
|
8.59 M | - | -26.83 % | $ 2.62 M | ||
|
Allied Healthcare Products
AHPI
|
7.81 M | - | 3.58 % | $ 2.21 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
11.2 M | - | -5.86 % | $ 30.6 M | ||
|
Second Sight Medical Products
EYES
|
24.7 M | - | -0.97 % | $ 54.4 M | ||
|
Conformis
CFMS
|
69.5 M | - | - | $ 16.4 M | ||
|
Integra LifeSciences Holdings Corporation
IART
|
794 M | $ 9.44 | -1.05 % | $ 727 M | ||
|
Helius Medical Technologies
HSDT
|
12.5 M | $ 2.13 | 5.97 % | $ 1.29 M | ||
|
InMode Ltd.
INMD
|
136 M | $ 13.75 | 0.36 % | $ 889 M | ||
|
Cardiovascular Systems
CSII
|
209 M | - | 0.15 % | $ 844 M | ||
|
Inogen
INGN
|
184 M | $ 6.37 | 0.71 % | $ 169 M | ||
|
IRadimed Corporation
IRMD
|
38.2 M | $ 102.03 | 1.04 % | $ 1.3 B | ||
|
Apollo Endosurgery
APEN
|
73.8 M | - | - | $ 475 M | ||
|
Avinger
AVGR
|
18.6 M | - | -20.74 % | $ 369 K | ||
|
CryoLife, Inc.
CRY
|
165 M | - | -4.14 % | $ 702 M | ||
|
LivaNova PLC
LIVN
|
697 M | $ 62.63 | 0.36 % | $ 3.42 B | ||
|
LENSAR
LNSR
|
32.6 M | $ 5.56 | -0.09 % | $ 64 M | ||
|
AxoGen
AXGN
|
121 M | $ 33.39 | 2.39 % | $ 1.54 B | ||
|
CONMED Corporation
CNMD
|
648 M | $ 36.6 | 0.11 % | $ 1.14 B | ||
|
Soliton, Inc.
SOLY
|
14.4 M | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
9.14 K | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
39.1 M | - | 0.03 % | $ 1.58 B | ||
|
NanoVibronix
NAOV
|
5.09 M | - | - | $ 1.08 M | ||
|
Electromed
ELMD
|
40.3 M | $ 24.95 | 1.01 % | $ 211 M | ||
|
Misonix, Inc.
MSON
|
63.1 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
36.4 M | - | - | $ 111 M | ||
|
Medtronic PLC
MDT
|
15.3 B | $ 86.5 | -0.09 % | $ 111 B | ||
|
MiMedx Group
MDXG
|
277 M | $ 4.16 | 0.73 % | $ 615 M | ||
|
Intersect ENT, Inc.
XENT
|
118 M | - | - | $ 955 M | ||
|
Cytosorbents Corporation
CTSO
|
41.9 M | $ 0.67 | -3.06 % | $ 36.5 M | ||
|
Aethlon Medical
AEMD
|
9.34 M | $ 2.34 | 8.33 % | $ 3.65 M | ||
|
BIOLASE
BIOL
|
34.7 M | - | -13.19 % | $ 166 K | ||
|
InspireMD
NSPR
|
52.3 M | $ 1.78 | 0.56 % | $ 114 M | ||
|
Orthofix Medical
OFIX
|
344 M | $ 11.78 | 0.51 % | $ 467 M | ||
|
AdaptHealth Corp.
AHCO
|
59.6 M | $ 11.59 | 0.96 % | $ 1.57 B | ||
|
Myomo
MYO
|
41.3 M | $ 0.71 | 0.94 % | $ 29.7 M | ||
|
Nano-X Imaging Ltd.
NNOX
|
60 M | $ 2.36 | -1.88 % | $ 138 M | ||
|
Penumbra
PEN
|
753 M | $ 335.55 | 0.41 % | $ 13.1 B | ||
|
Invacare Corporation
IVC
|
260 M | - | - | $ 24.7 M | ||
|
EDAP TMS S.A.
EDAP
|
20.8 M | $ 3.75 | -4.09 % | $ 140 M | ||
|
Quanterix Corporation
QTRX
|
191 M | $ 4.07 | 6.64 % | $ 174 M | ||
|
OrthoPediatrics Corp.
KIDS
|
212 M | $ 16.09 | 1.13 % | $ 377 M | ||
|
Insulet Corporation
PODD
|
531 M | $ 222.68 | -1.25 % | $ 15.7 B |